Valsts: Izraēla
Valoda: angļu
Klimata pārmaiņas: Ministry of Health
TRAVOPROST
K.S.KIM INTERNATIONAL (SK- PHARMA) LTD., ISRAEL
S01EE04
OPHTHALMIC SOLUTION
TRAVOPROST 0.04 MG/ML
OCULAR
Required
RAFARM S.A., GREECE
TRAVOPROST
For the reduction of elevated intra ocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other IOP lowering medications or insufficiently responsive to another IOP lowering medication
2019-05-30
PACKAGE INSERT IN ACCORDANCE WITH THE PHARMACISTS REGULATIONS (PREPARATIONS) - 1986 The medication is marketed by doctor’s prescription only TRAVOPROST S.K. Eye drops (solution) Active ingredient: Travoprost 40mcg/ml Inactive ingredients in the preparation are listed in the “Additional Information” chapter at the end of the leaflet (Section 6). READ THE LEAFLET CAREFULLY IN ITS ENTIRETY BEFORE USING THE MEDICATION. This leaflet contains concise information on the medication. If you have further questions, refer to the doctor or pharmacist. This medication was prescribed for the treatment of your disease. Do not pass it on to others. It might harm them even if it seems to you that their medical condition is similar. 1. WHAT IS THIS MEDICATION INTENDED FOR? MEDICAL ACTIVITY: The medication is intended to reduce intraocular pressure in patients with open-angle glaucoma or patients who are insufficiently responsive to other drugs intended for the same purpose. THERAPEUTIC GROUP: Prostaglandin analog 2. BEFORE USING THE MEDICATION DO NOT USE THE MEDICATION IF: ∙ You are pregnant, breastfeeding or while undergoing a fertility treatment. ∙You have a known sensitivity to any of the ingredients in the medicine. WARNINGS ∙The medicine is not intended for children. ∙A change in the color of the iris may occur during treatment. There may also be effects of lengthening of eyelashes, and/or change in their color, thickening of eyelashes and/or change in the number of eyelashes, unusual growth of eyelid hair. These changes might sometimes be permanent. ∙ In rare cases, shortness of breath, wheezing, increased asthma symptoms may develop. If you are concerned about changes in your breathing, consult a doctor. ∙ The medicine may be absorbed through the skin. If the preparation comes in contact with the skin, wash immediately, especially in pregnant women or in women who are trying to conceive. ∙ If you underwent a cataract surgery, inform the doctor before starting to use the medicine. ∙ If you have suffered Izlasiet visu dokumentu